Efficacy and Safety of AQX-1125 in Unstable COPD

NCT01954628 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: AQX-1125
DRUG: Placebo

Sponsor

Aquinox Pharmaceuticals (Canada) Inc.